A genome-based functional screening approach to vaccine development that combines in vitro assays and DNA immunization

Vaccine

Volumn 21, Issue 23, 2003, Pages 3259-3264

  Delcayre, Alain ^a,b   Peake, John S ^a   White, Damian J ^a   Yuan, Shining ^a   McDonald, Megan K ^a   Liang, Andrew ^a   Tan, Paul L ^a   Watson, James D ^a  

^a Genesis Research & Development Corporation Ltd   (New Zealand)

^b Anosys Inc   (United States)

Author keywords

Genome based approach; Tuberculosis; Vaccine

Indexed keywords

DNA; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; FEMALE; GENOME; IMMUNIZATION; IMMUNOGENICITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; SCREENING; SPLEEN CELL; T LYMPHOCYTE; TUBERCULOSIS;

EID: 0038543352     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00236-6     Document Type: Article

References (20)

1. Hinnan A.R. Global progress in infectious disease control. Vaccine. 16:1998;1116-1121.
2. Barry M.A., Lai W.C., Jonhston S.A. Protection against mycoplasma infection using expression-library immunization. Nature. 377:1995;632-635.
3. Hoffman S.L., Rogers W.O., Carucci D.J., Venter J.C. From genomics to vaccines: malaria as a model system. Nat. Med. 4:1998;1351-1353.
4. Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine. 19:2001;2688-2691.
5. Hill A.V., Davenport M.P. Reverse immunogenetics: from HLA-disease associations to vaccine candidates. Mol. Med. Today. 2(1):1996;38-45.
6. De Groot A.S., Bosma A., Chinai N., Frost J., Jesdale B.M., Gonzalez M.A.et al. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine. 19:2001;4385-4395.
7. Pandha H.S., Mortimer P., Souberbeille B., McCoubrie P., O'Brien M.E. Cutaneous toxicity after intradermal vaccination with Mycobacterium vaccae against lung cancer and malignant mesothelioma. Br. J. Dermatol. 144(3):2001;648-649.
8. Balagon M.V., Tan P.L., Prestidge R.V., Cellona R.V., Abalos R.M., Tan E.V.et al. Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC™): results of an open-label trial. Clin. Exp. Dermatol. 26:2001;233-241.
9. Arkwright P.D., David T.J. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J. Allergy Clin. Immunol. 107:2001;531-534.
10. Stanford J.L., Stanford C.A., Grange J.M., Lan N.N., Etemadi A. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis? Respir. Med. 95:2001;444-447.
11. Skinner M.A., Yuan S., Prestidge R.L., Chuk D., Watson J.D., Tan P.L.J. Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. Infect. Immun. 65:1997;4525-4530.
12. Hernandez-Pando R., Pavon L., Arriaga K., Orozco H., Madrid-Marina V., Rook G.A.W. Improvement and exacerbation of murine tuberculosis by previous exposure to low and high doses of an environmental mycobacterial saprophyte. Infect. Immun. 65:1997;3317-3327.
13. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., Lowrie D.B. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:1996;888-892.
14. Skinner M.A., Prestidge R., Yuan S., Strabala T.J., Tan P.L.J. The ability of heat-killed Mycobacterium vaccae to stimulate a cytotoxic T-cell response to an unrelated protein is associated with a 65 kilodalton heat-shock protein. Immunology. 102:2001;225-233.
15. Chu N.R., Wu H.B., Wu T.C., Boux L.J., Mizzen L.A., Siegel M.I. Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7. Cell Stress Chaper. 5:2000;401-405.
16. Huygen K., Content J., Denis O. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:1996;893-898.
17. Cardona P.J., Llatjos R., Gordillo S., Diaz J., Vinado B., Ariza A.et al. Towards a 'human-like' model of tuberculosis: intranasal inoculation of LPS induces intragranulomatous lung necrosis in mice infected aerogenically with Mycobacterium tuberculosis. Scand J. Immunol. 53:2001;65-71.
18. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:1993;2243-2247.
19. Newport M.J., Huxley C.M., Huston S., Hawrylowiccz C.M., Oostra B.A., Williamson R.et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 355:1996;1941-1945.
20. + T-cell priming against the identified peptides after DNA vaccination of mice. Vaccine. 16:1998;692-697.